Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF


Cetin G. Y. , Balkarli A., Oksuz A. N. , Kimyon G., Pehlivan Y., Orhan O., ...More

REVISTA BRASILEIRA DE REUMATOLOGIA, vol.54, no.5, pp.356-359, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 54 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1016/j.rbr.2014.03.022
  • Journal Name: REVISTA BRASILEIRA DE REUMATOLOGIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.356-359
  • Bursa Uludag University Affiliated: Yes

Abstract

Introduction: Colchicine is the mainstay for the treatment of FMF, which is an auto- inflammatory disease mainly with relapsing polyserositis. Despite daily doses of 2 mg or more each day, approximately 5% to 10% of the patients continue to suffer from its attacks. In this study, we aimed to investigate the depression and attack features in patients with FMF who have colchicine resistance (CR).